Recurrent Colon Carcinoma Completed Phase 1 Trials for Fluorouracil (DB00544)

Also known as: Carcinoma colon recurrent / Colon carcinoma recurrent / Colon cancer recurrent

IndicationStatusPhase
DBCOND0047445 (Recurrent Colon Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01383343Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerTreatment